Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice

Stem Cell Research and Therapy

Volumn 7, Issue 1, 2016, Pages 1-11

  Li, Yan ^a,b   Xu, Jun ^a   Shi, Weiqing ^a   Chen, Cheng ^a   Shao, Yan ^a   Zhu, Limei ^a   Lu, Wei ^a   Han, XiaoDong ^b  

^a JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Cell therapy; H9N2 avian influenza viruses; Lung injury; Mesenchymal stromal cell

Indexed keywords

CYTOKINE; CHEMOKINE;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CELL DIFFERENTIATION; CELL THERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; INFLAMMATORY CELL; INFLUENZA A VIRUS (H9N2); LUNG WEIGHT; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SURVIVAL RATE; ANIMAL; C57BL MOUSE; CYTOLOGY; LUNG; METABOLISM; ORTHOMYXOVIRIDAE INFECTIONS; PATHOLOGY; VIROLOGY;

ACUTE LUNG INJURY; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; FEMALE; INFLUENZA A VIRUS, H9N2 SUBTYPE; LUNG; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA; SURVIVAL RATE;

EID: 84992697333     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/s13287-016-0395-z     Document Type: Article

References (45)

1. Si Y, de Boer WF, Gong P. Different environmental drivers of highly pathogenic avian influenza H5N1 outbreaks in poultry and wild birds. PLoS One. 2013;8:e53362.
2. Qi X, Cui L, Jiao Y, Pan Y, Li X, Zu R, Huo X, Wu B, Tang F, Song Y, Zhou M, Wang H, Cardona CJ, Xing Z. Antigenic and genetic characterization of a European avian-like H1N1 swine influenza virus from a boy in China in 2011. Arch Virol. 2013;158:39-53.
3. Metras R, Stevens KB, Abdu P, Okike I, Randolph T, Grace D, Pfeiffer DU, Costard S. Identification of potential risk factors associated with highly pathogenic avian influenza subtype H5N1 outbreak occurrence in Lagos and Kano States, Nigeria, during the 2006-2007 epidemics. Transbound Emerg Dis. 2013;60:87-96.
4. Parker CD, Reid SM, Ball A, Cox WJ, Essen SC, Hanna A, Mahmood S, Slomka MJ, Irvine RM, Brown IH. First reported detection of a low pathogenicity avian influenza virus subtype H9 infection in domestic fowl in England. Vet Rec. 2012;171:372.
5. Younan M, Poh MK, Elassal E, Davis T, Rivailler P, Balish AL, Simpson N, Jones J, Deyde V, Loughlin R, Perry I, Gubareva L, ElBadry MA, Truelove S, Gaynor AM, Mohareb E, Amin M, Cornelius C, Pimentel G, Earhart K, Naguib A, Abdelghani AS, Refaey S, Klimov AI, Donis RO, Kandeel A. Microevolution of highly pathogenic avian influenza A(H5N1) viruses isolated from humans, Egypt, 2007-2011. Emerg Infect Dis. 2013;19:43-50.
6. Su S, Qi W, Chen J, Zhu W, Huang Z, Xie J, Zhang G. Seroepidemiological evidence of avian influenza A virus transmission to pigs in southern China. J Clin Microbiol. 2013;51:601-2.
7. Kandun IN, Tresnaningsih E, Purba WH, Lee V, Samaan G, Harun S, Soni E, Septiawati C, Setiawati T, Sariwati E, Wandra T. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet. 2008;372:744-9.
8. Tam JS. Influenza A, (H5N1) in Hong Kong: an overview. Vaccine. 2002;20 Suppl 2:S77-81.
9. Peiris M, Yuen KY, Leung CW, Chan KH, Ip PL, Lai RW, Orr WK, Shortridge KF. Human infection with influenza H9N2. Lancet. 1999;354:916-7.
10. Butt KM, Smith GJ, Chen H, Zhang LJ, Leung YH, Xu KM, Lim W, Webster RG, Yuen KY, Peiris JS, Guan Y. Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol. 2005;43:5760-7.
11. Tombari W, Paul M, Bettaieb J, Larbi I, Nsiri J, Elbehi I, Gribaa L, Ghram A. Risk factors and characteristics of low pathogenic avian influenza virus isolated from commercial poultry in Tunisia. PLoS One. 2013;8:e53524.
12. Kim HR, Lee KK, Kwon YK, Kang MS, Moon OK, Park CK. Comparison of serum treatments to remove nonspecific inhibitors from chicken sera for the hemagglutination inhibition test with inactivated H5N1 and H9N2 avian influenza A virus subtypes. J Vet Diagn Invest. 2012;24:954-8.
13. Lin YP, Shaw M, Gregory V, Cameron K, Lim W, Klimov A, Subbarao K, Guan Y, Krauss S, Shortridge K, Webster R, Cox N, Hay A. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci U S A. 2000;97:9654-8.
14. Ortiz JR, Rudd KE, Clark DV, Jacob ST, West TE. Clinical research during a public health emergency: a systematic review of severe pandemic influenza management. Crit Care Med. 2013;41:1345-52.
15. Hsu J, Santesso N, Mustafa R, Brozek J, Chen YL, Hopkins JP, Cheung A, Hovhannisyan G, Ivanova L, Flottorp SA, Saeterdal I, Wong AD, Tian J, Uyeki TM, Akl EA, Alonso-Coello P, Smaill F, Schunemann HJ. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med. 2012;156:512-24.
16. Uno Y, Usui T, Soda K, Fujimoto Y, Takeuchi T, Ito H, Ito T, Yamaguchi T. The pathogenicity and host immune response associated with H5N1 highly pathogenic avian influenza virus in quail. J Vet Med Sci. 2013;75:451-7.
17. Ramos I, Fernandez-Sesma A. Innate immunity to H5N1 influenza viruses in humans. Viruses. 2012;4:3363-88.
18. Ling MT, Tu W, Han Y, Mao H, Chong WP, Guan J, Liu M, Lam KT, Law HK, Peiris JS, Takahashi K, Lau YL. Mannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infection. J Infect Dis. 2012;205:44-53.
19. Viemann D, Schmolke M, Lueken A, Boergeling Y, Friesenhagen J, Wittkowski H, Ludwig S, Roth J. H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response. J Immunol. 2011;186:164-73.
20. Warnke PH, Humpe A, Strunk D, Stephens S, Warnke F, Wiltfang J, Schallmoser K, Alamein M, Bourke R, Heiner P, Liu Q. A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies. J Craniomaxillofac Surg. 2013;41:153-61.
21. Schnerch A, Lee JB, Graham M, Guezguez B, Bhatia M. Human embryonic stem cell-derived hematopoietic cells maintain core epigenetic machinery of the polycomb group/trithorax group complexes distinctly from functional adult hematopoietic stem cells. Stem Cells Dev. 2013;22:73-89.
22. Toonkel RL, JM Hare, MA Matthay, MK Glassberg. Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing. Am J Respir Crit Care Med. 2013;188:133-40.
23. Waszak P, Alphonse R, Vadivel A, Ionescu L, Eaton F, Thebaud B. Preconditioning enhances the paracrine effect of mesenchymal stem cells in preventing oxygen-induced neonatal lung injury in rats. Stem Cells Dev. 2012;21:2789-97.
24. Wang N, Li Q, Zhang L, Lin H, Hu J, Li D, Shi S, Cui S, Zhou J, Ji J, Wan J, Cai G, Chen X. Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6. PLoS One. 2012;7:e43768.
25. Maria Spaggiari G, Moretta L. Cellular and molecular interactions of mesenchymal stem cells in innate immunity. Immunol Cell Biol. 2013;91:27-31.
26. Reddy BY, Xu DS, Hantash BM. Mesenchymal stem cells as immunomodulator therapies for immune-mediated systemic dermatoses. Stem Cells Dev. 2012;21:352-62.
27. Gharaee-Kermani M, Gyetko MR, Hu B, Phan SH. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy. Pharm Res. 2007;24:819-41.
28. Xia J, Zhang H, Sun B, Yang R, He H, Zhan Q. Spontaneous breathing with biphasic positive airway pressure attenuates lung injury in hydrochloric acid-induced acute respiratory distress syndrome. Anesthesiology. 2014;120:1441-9.
29. Butt AM, Siddique S, Idrees M, Tong Y. Avian influenza A (H9N2): computational molecular analysis and phylogenetic characterization of viral surface proteins isolated between 1997 and 2009 from the human population. Virol J. 2010;7:319.
30. Ashour MM, Khatab AM, El-Folly RF, Amer WA. Clinical features of avian influenza in Egyptian patients. J Egypt Soc Parasitol. 2012;42:385-96.
31. Li C, Bankhead 3rd A, Eisfeld AJ, Hatta Y, Jeng S, Chang JH, Aicher LD, Proll S, Ellis AL, Law GL, Waters KM, Neumann G, Katze MG, McWeeney S, Kawaoka Y. Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus. J Virol. 2011;85:10955-67.
32. Cilloniz C, Shinya K, Peng X, Korth MJ, Proll SC, Aicher LD, Carter VS, Chang JH, Kobasa D, Feldmann F, Strong JE, Feldmann H, Kawaoka Y, Katze MG. Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog. 2009;5:e1000604.
33. Zeng H, Pappas C, Belser JA, Houser KV, Zhong W, Wadford DA, Stevens T, Balczon R, Katz JM, Tumpey TM. Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: possible involvement in the pathogenesis of human H5N1 virus infection. J Virol. 2012;86:667-78.
34. Ferreira HL, Pirlot JF, Reynard F, van den Berg T, Bublot M, Lambrecht B. Immune responses and protection against H5N1 highly pathogenic avian influenza virus induced by the Newcastle disease virus H5 vaccine in ducks. Avian Dis. 2012;56:940-8.
35. Filali M, Liu X, Cheng N, Abbott D, Leontiev V, Engelhardt JF. Mechanisms of submucosal gland morphogenesis in the airway. Novartis Found Symp. 2002;248:38-45. discussion -50, 277-82.
36. Kim DW, Staples M, Shinozuka K, Pantcheva P, Kang SD, Borlongan CV. Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci. 2013;14:11692-712.
37. Xue J, Li X, Lu Y, Gan L, Zhou L, Wang Y, Lan J, Liu S, Sun L, Jia L, Mo X, Li J. Gene-modified mesenchymal stem cells protect against radiation-induced lung injury. Mol Ther. 2013;21:456-65.
38. Toonkel RL, Hare JM, Matthay MA, Glassberg MK. Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing. Am J Respir Crit Care Med. 2013;188:133-40.
39. Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC, Stewart DJ. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med. 2007;4:e269.
40. Zhang S, Wang Y, Mao JH, Hsieh D, Kim IJ, Hu LM, Xu Z, Long H, Jablons DM, You L. Inhibition of CK2alpha down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cells. PLoS One. 2012;7:e38996.
41. Alphonse RS, Rajabali S, Thebaud B. Lung injury in preterm neonates: the role and therapeutic potential of stem cells. Antioxid Redox Signal. 2012;17:1013-40.
42. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009;15:42-9.
43. Puneet P, Moochhala S, Bhatia M. Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2005;288:L3-15.
44. Lam WY, Yeung AC, Ngai KL, Li MS, To KF, Tsui SK, Chan PK. Effect of avian influenza A H5N1 infection on the expression of microRNA-141 in human respiratory epithelial cells. BMC Microbiol. 2013;13:104.
45. Wang Y, Sun Z, Qiu X, Li Y, Qin J, Han X. Roles of Wnt/beta-catenin signaling in epithelial differentiation of mesenchymal stem cells. Biochem Biophys Res Commun. 2009;390:1309-14.